Protalix (PLX) in Focus: Stock Adds 6.5% in Session

Zacks

Protalix BioTherapeutics, Inc. (PLX) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $3.80 to $4.00.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Protalix currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some well-placed Bio-Med stocks that warrant a look are ANI Pharmaceuticals, Inc. (ANIP), Gilead Sciences Inc. (GILD) and Illumina Inc. (ILMN). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



PROTALIX BIOTHERAPEUTICS INC (PLX): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)